EWA
CRVO icon

EverSource Wealth Advisors’s CervoMed CRVO Stock Holding History

EverSource Wealth Advisors’s Portfolio CRVO Stock Details CRVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$366 Buy
+118
New +$416 ﹤0.01% 4175
2025
Q3 		– Sell
-36
Closed -$226 – 4353
2025
Q2 		$226 Hold
36
– – ﹤0.01% 4041
2025
Q1 		$329 Buy
+36
New +$137 ﹤0.01% 3580

Other funds holding CRVO

WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SM
Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BAM
Byrne Asset Management Kingston, New Jersey $185M AUM 41.05% 1-Year Est. Return
CFG
Citizens Financial Group Providence, Rhode Island $8.3B AUM 27.66% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
TDC
Thompson Davis & Co Richmond, Virginia $167M AUM 33.45% 1-Year Est. Return

EverSource Wealth Advisors's CRVO Position: Q2 2026 in Review

EverSource Wealth Advisors opened a new position in CervoMed (CRVO) in Q2 2026: 118 shares worth $366. The stake represents ﹤0.01% of the portfolio and ranks #4175 among its holdings. This is a return to the name: EverSource Wealth Advisors previously reported a position in CRVO as recently as Q2 2025.

EverSource Wealth Advisors first reported a position in CRVO in Q1 2025 and has held it in 3 quarters since. 37 funds tracked by Wall St. Rank hold CRVO as of Q2 2026.

  • EverSource Wealth Advisors held 118 shares of CervoMed worth $366 as of Q2 2026.
  • CervoMed was a new EverSource Wealth Advisors position in Q2 2026.
  • CervoMed made up ﹤0.01% of EverSource Wealth Advisors's portfolio in Q2 2026, its #4175 holding.
  • EverSource Wealth Advisors first reported a position in CervoMed in Q1 2025 and has held it in 3 quarters since.
  • 37 funds tracked by Wall St. Rank held CervoMed as of Q2 2026.

Based on EverSource Wealth Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.